Current status: 1069 hESC lines, 6830 hiPSC lines, and 173 clinical studies, and 2394 certificates
Monthly statistic from Feb 1, 2025
Posted on February 1, 2025
total lines | 7899 |
hESC lines | 1069 |
hiPSC lines | 6830 |
derivation countries | 50 |
projects | 313 |
providers | 963 |
clinical studies | 173 |
subclones | 3339 |
certificates | 2394 |
cell line certificates | 2247 |
project certificates | 147 |